Rokit Healthcare

Rokit Healthcare EBIT per Share

The EBIT per Share of Rokit Healthcare (376900.KQ) as of Nov 1, 2026 is 29.38 KRW. In the previous year, EBIT per Share was 799.36 KRW — a change of -96.32% (lower).

EBIT per Share

29.38KRW

YoY

-96.32%

Last updated:

EBIT per Share of Rokit Healthcare is 2025 29.38 KRW. EBIT per Share of Rokit Healthcare was 2024 799.36 KRW. It decreases by -96.32% lower compared to the previous year.

The Rokit Healthcare EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
799.36 KRW
Jan 1, 2025
29.38 KRW
Jan 1, 2026 (e)
662.15 KRW
The Rokit Healthcare EBIT per Share history
YEAREBIT per ShareYoY
est662.15KRW+2,153.77%
29.38KRW-96.32%
799.36KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rokit Healthcare Stock analysis

What does Rokit Healthcare do? Rokit Healthcare Inc develops and sells medical supplies and pharmaceutical products through its AI organ regeneration platform. The company offers three core services: medical 3-dimensional (3D) bioprinting using biocompatible materials, AI automated precision modeling for affected areas, and disposable medical device kits for assembly and disassembly. These services target healthcare providers and medical institutions seeking advanced solutions for organ regeneration and precision medical procedures. The firm also engages in manufacturing, development, sales, wholesale, and retail of medical devices, supporting both domestic and international markets. The medical 3D bioprinting service creates 3D structures with biomaterials, while the AI automated precision modeling service uses artificial intelligence to model affected areas accurately. Disposable medical device kits are sterile and designed for direct assembly and disassembly, catering to hospitals and clinics requiring efficient, sterile medical tools. Rokit Healthcare Inc's business model focuses on delivering integrated AI-driven medical solutions that combine bioprinting, modeling, and disposable device kits to enhance patient care and surgical precision. Rokit Healthcare Inc's primary revenue streams come from the sale of its AI organ regeneration platform services and the associated medical devices. Healthcare providers and medical institutions purchase these services and products to improve treatment outcomes and streamline surgical processes. The company's manufacturing and distribution activities in medical devices further contribute to its revenue, with a strong emphasis on innovation in AI and bioprinting technologies to maintain market competitiveness. Rokit Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rokit Healthcare stock

EBIT per Share of Rokit Healthcare is 29.38 KRW in 2025.

EBIT per Share of Rokit Healthcare changed from 799.36 KRW to 29.38 KRW, representing a -96.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Rokit Healthcare since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Rokit Healthcare

All Key Metrics — Rokit Healthcare